₹5,000 Monthly SIP in Nippon India Pharma Fund-Growth Plan for 3 Years
If you had started a ₹5,000/month SIP on 29 Sept 2023 and never stopped — through every crash and rally — here is exactly what happened, using Nippon India Pharma Fund-Growth Plan's actual NAV for all 37 installments.
You invested
₹1,85,000
37 installments
Value today
₹2,23,230
28 Sept 2026
Absolute gain
+₹38,230
+20.7%
XIRR (annualised)
12.32%
money-weighted
The journey, month by month
Worst fall on the way
-12.2%
Deepest drop from peak. This is what you had to sit through.
Corrections survived
1
Falls of 10%+ during the period. Every one recovered.
Same SIP in a fixed deposit
₹2,06,398
Modelled at historical FD rates. The fund beat FD by ₹16,832.
Year-by-year progress
| Year | Invested | Value | Overall gain |
|---|---|---|---|
| Year 1 (30 Sept 2024) | ₹65,000 | ₹82,865 | +27.5% |
| Year 2 (29 Sept 2025) | ₹1,25,000 | ₹1,38,403 | +10.7% |
| Year 3 (28 Sept 2026) | ₹1,85,000 | ₹2,23,230 | +20.7% |
Best year of the journey: Year 1 (+27.5% market move) · Toughest year: Year 2 (-3.1%)
Wealth Time Machine
Watch this exact journey as a 60-second cinematic replay
Every crash headline, every recovery — with your money in it.
Try a different amount
Try a different duration
Past performance does not guarantee future returns. This page shows the historical result of the stated SIP using Nippon India Pharma Fund-Growth Plan's published NAV (source: AMFI) between 29 Sept 2023 and 28 Sept 2026; it is educational research, not investment advice. FD comparison is modelled at historical average FD rates. Mutual fund investments are subject to market risks.
